TerrAscend (OTCMKTS:TSNDF – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02), Zacks reports. TerrAscend had a negative return on equity of 24.69% and a negative net margin of 45.86%.
TerrAscend Stock Performance
TerrAscend stock traded up $0.05 during trading on Thursday, reaching $0.52. The company had a trading volume of 186,901 shares, compared to its average volume of 334,215. The firm has a market capitalization of $161.30 million, a price-to-earnings ratio of -5.22 and a beta of 1.39. The company has a current ratio of 1.51, a quick ratio of 0.98 and a debt-to-equity ratio of 2.66. The firm’s 50-day simple moving average is $0.62 and its 200 day simple moving average is $0.65. TerrAscend has a 52 week low of $0.35 and a 52 week high of $1.45.
About TerrAscend
TerrAscend is a vertically integrated cannabis company that operates across cultivation, processing and retailing in North America. The company’s business model spans seed-to-sale activities, enabling it to manage quality control, production efficiency and product innovation from its growing facilities through to its distribution networks. TerrAscend serves both adult-use and medical cannabis markets, offering a full suite of cannabis derivatives including dried flower, concentrates, vapes, edibles, tinctures and topicals.
Geographically, TerrAscend maintains operations in key regulated markets.
See Also
- Five stocks we like better than TerrAscend
- Sandisk Just Delivered a Blowout Quarter—Here’s Why the Stock Is Falling
- 4 Oil and Gas ETF Plays as Prices Stay Sky-High
- What Tesla Stands to Lose If It Walks Away From China
- Disney Sets Up for a Magical Year in 2027
Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.
